
Tag: Food & Drug Administration


Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19

Tetra Bio-Pharma Receives Conditional Approval to Graduate to the TSX

Naturally Splendid Provides Clinical Trial Application Update
